Skip to main content
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases 5/2006

01.05.2006 | Concise Article

Macrolide use identified as risk factor for macrolide-resistant Streptococcus pneumoniae in a 17-center case-control study

verfasst von: S. E. Beekmann, D. J. Diekema, K. P. Heilmann, S. S. Richter, G. V. Doern

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 5/2006

Einloggen, um Zugang zu erhalten

Abstract

The objective of the case-control study presented here was to examine the risk factors for macrolide-resistant Streptococcus pneumoniae. As part of a 44-center U.S. surveillance study, 1,817 unique isolates of S. pneumoniae were collected from November 2002 through April 2003. Seventy-five randomly selected macrolide-resistant isolates (cases) were each matched with one susceptible control. Macrolide use in the 6 weeks prior to sample collection was reported for seven cases and one control. The final conditional logistic regression model identified two statistically significant variables: a history of alcohol abuse was protective, while macrolide use in the 6 weeks prior to sample collection was a significant risk factor for macrolide-resistant S. pneumoniae. Macrolide resistance was associated with use of any antibiotic during the prior 6 weeks, and was most strongly associated with previous macrolide use.
Literatur
1.
Zurück zum Zitat Syrogiannopoulos GA, Grivea IN, Davies TA, Katopodis GD, Appelbaum PC, Beratis NG (2000) Antimicrobial use and colonization with erythromycin-resistant Streptococcus pneumoniae in Greece during the first 2 years of life. Clin Infect Dis 31:887–893PubMedCrossRef Syrogiannopoulos GA, Grivea IN, Davies TA, Katopodis GD, Appelbaum PC, Beratis NG (2000) Antimicrobial use and colonization with erythromycin-resistant Streptococcus pneumoniae in Greece during the first 2 years of life. Clin Infect Dis 31:887–893PubMedCrossRef
2.
Zurück zum Zitat Leach AJ, Shelby-James TM, Mayo M, Gratten M, Laming AC, Currie BJ, Mathews JD (1997) A prospective study of the impact of community-based azithromycin treatment of trachoma on carriage and resistance of Streptococcus pneumoniae. Clin Infect Dis 24:356–362PubMed Leach AJ, Shelby-James TM, Mayo M, Gratten M, Laming AC, Currie BJ, Mathews JD (1997) A prospective study of the impact of community-based azithromycin treatment of trachoma on carriage and resistance of Streptococcus pneumoniae. Clin Infect Dis 24:356–362PubMed
3.
Zurück zum Zitat Klugman K, Lonks JR (2005) Hidden epidemic of macrolide-resistant pneumococci. Emerg Infect Dis 11:802–807PubMed Klugman K, Lonks JR (2005) Hidden epidemic of macrolide-resistant pneumococci. Emerg Infect Dis 11:802–807PubMed
4.
Zurück zum Zitat Kastner U, Guggenbichler JP (2001) Influence of macrolide antibiotics on promotion of resistance in the oral flora of children. Infection 29:251–256PubMedCrossRef Kastner U, Guggenbichler JP (2001) Influence of macrolide antibiotics on promotion of resistance in the oral flora of children. Infection 29:251–256PubMedCrossRef
5.
Zurück zum Zitat Garcia-Rey C, Aguilar L, Baquero F, Casal J, Dal-Re R (2002) Importance of local variations in antibiotic consumption and geographical differences of erythromycin and penicillin resistance in Streptococcus pneumoniae. J Clin Microbiol 40:159–164PubMedCrossRef Garcia-Rey C, Aguilar L, Baquero F, Casal J, Dal-Re R (2002) Importance of local variations in antibiotic consumption and geographical differences of erythromycin and penicillin resistance in Streptococcus pneumoniae. J Clin Microbiol 40:159–164PubMedCrossRef
6.
Zurück zum Zitat Barkai G, Greenberg D, Givon-Lavi N, Dreifuss E, Vardy D, Dagan R (2005) Community prescribing and resistant Streptococcus pneumoniae. Emerg Infect Dis 11:829–837PubMed Barkai G, Greenberg D, Givon-Lavi N, Dreifuss E, Vardy D, Dagan R (2005) Community prescribing and resistant Streptococcus pneumoniae. Emerg Infect Dis 11:829–837PubMed
7.
Zurück zum Zitat Doern GV, Richter SS, Miller A, Miller N, Rice C, Heilmann KP, Beekmann SE (2005) Antimicrobial resistance among Streptococcus pneumoniae in the United States: have we begun to turn the corner on resistance to certain antimicrobial classes? Clin Infect Dis 41:139–148PubMedCrossRef Doern GV, Richter SS, Miller A, Miller N, Rice C, Heilmann KP, Beekmann SE (2005) Antimicrobial resistance among Streptococcus pneumoniae in the United States: have we begun to turn the corner on resistance to certain antimicrobial classes? Clin Infect Dis 41:139–148PubMedCrossRef
8.
Zurück zum Zitat Vanderkooi OG, Low DE, Green K, Powis JE, McGeer A, for the Toronto Invasive Bacterial Disease Network (2005) Predicting antimicrobial resistance in invasive pneumococcal infections. Clin Infect Dis 40:1288–1297PubMedCrossRef Vanderkooi OG, Low DE, Green K, Powis JE, McGeer A, for the Toronto Invasive Bacterial Disease Network (2005) Predicting antimicrobial resistance in invasive pneumococcal infections. Clin Infect Dis 40:1288–1297PubMedCrossRef
9.
Zurück zum Zitat Harris AD, Karchmer TB, Carmeli Y, Samore MH (2001) Methodological principles of case-control studies that analyzed risk factors for antibiotic resistance: a systematic review. Clin Infect Dis 32:1055–1061PubMedCrossRef Harris AD, Karchmer TB, Carmeli Y, Samore MH (2001) Methodological principles of case-control studies that analyzed risk factors for antibiotic resistance: a systematic review. Clin Infect Dis 32:1055–1061PubMedCrossRef
10.
Zurück zum Zitat Kaye KS, Engemann JJ, Mozaffari E, Carmeli Y (2004) Reference group choice and antibiotic resistance outcomes. Emerg Infect Dis 10:1125–1128PubMed Kaye KS, Engemann JJ, Mozaffari E, Carmeli Y (2004) Reference group choice and antibiotic resistance outcomes. Emerg Infect Dis 10:1125–1128PubMed
11.
Zurück zum Zitat Kim BN, Bae IG, Kim MN, Park SJ, Woo JH, Ryu J, Kim YS (2002) Risk factors for penicillin resistance and mortality in Korean adults with Streptococcus pneumoniae bacteremia. Eur J Clin Microbiol Infect Dis 21:35–42PubMedCrossRef Kim BN, Bae IG, Kim MN, Park SJ, Woo JH, Ryu J, Kim YS (2002) Risk factors for penicillin resistance and mortality in Korean adults with Streptococcus pneumoniae bacteremia. Eur J Clin Microbiol Infect Dis 21:35–42PubMedCrossRef
12.
Zurück zum Zitat Clavo-Sanchez AJ, Giron-Gonzalez JA, Lopez-Prieto D, Canueto-Quintero J, Sanchez-Porto A, Vergara-Campos A, Marin-Casanova P, Cordoba-Dona JA (1997) Multivariate analysis of risk factors for infection due to penicillin-resistant and multidrug-resistant Streptococcus pneumoniae: a multicenter study. Clin Infect Dis 24:1052–1059PubMedCrossRef Clavo-Sanchez AJ, Giron-Gonzalez JA, Lopez-Prieto D, Canueto-Quintero J, Sanchez-Porto A, Vergara-Campos A, Marin-Casanova P, Cordoba-Dona JA (1997) Multivariate analysis of risk factors for infection due to penicillin-resistant and multidrug-resistant Streptococcus pneumoniae: a multicenter study. Clin Infect Dis 24:1052–1059PubMedCrossRef
13.
Zurück zum Zitat Doern GV (2001) Antimicrobial use and the emergence of antimicrobial resistance with Streptococcus pneumoniae in the United States. Clin Infect Dis 33(Suppl 3):187–192CrossRef Doern GV (2001) Antimicrobial use and the emergence of antimicrobial resistance with Streptococcus pneumoniae in the United States. Clin Infect Dis 33(Suppl 3):187–192CrossRef
14.
Zurück zum Zitat Edelstein PH (2002) Predicting the emergence of antimicrobial resistance [comment]. Clin Infect Dis 34:1418–1420PubMedCrossRef Edelstein PH (2002) Predicting the emergence of antimicrobial resistance [comment]. Clin Infect Dis 34:1418–1420PubMedCrossRef
Metadaten
Titel
Macrolide use identified as risk factor for macrolide-resistant Streptococcus pneumoniae in a 17-center case-control study
verfasst von
S. E. Beekmann
D. J. Diekema
K. P. Heilmann
S. S. Richter
G. V. Doern
Publikationsdatum
01.05.2006
Verlag
Springer-Verlag
Erschienen in
European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 5/2006
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-006-0137-8

Weitere Artikel der Ausgabe 5/2006

European Journal of Clinical Microbiology & Infectious Diseases 5/2006 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.